Large-scale clinical trials have confirmed that intensive insulin therapy can provide rapid and effective glycemic control, microcirculation and reduced substances harmful to the kidney, produced by the body in early type 2 diabetes mellitus patients, and thereby reducing the leakage of urine protein, slow the progression of DN [22]. This evidence concerns the gene INS and type 2 diabetes mellitus.